Springer Nature
Browse
12967_2019_1824_MOESM10_ESM.tif (276.04 kB)

MOESM10 of Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma

Download (276.04 kB)
figure
posted on 2019-03-04, 05:00 authored by Qian Song, Jun Shang, Zuyi Yang, Lanlin Zhang, Chufan Zhang, Jianing Chen, Xianghua Wu
Additional file 10: Figure S8. The Kaplan–Meier survival analysis of the signature for LUAD subgroup patients in GSE31210 dataset. Patients of high-risk exhibited poor prognosis in stage I cohort (P < 0.05). There was no association of the risk score with patients of stage II cohort, recurrence cohort, and no recurrence cohort.

History